Abstract PS12-06: Phase II randomized trial of fulvestrant with or without enzalutamide in ER+/Her2- primary breast cancer (BC)
Elias, Anthony D, Fournier, Monica, Vidal, Gregory A, Sams, Sharon, Spoelsta, Nicole, Kabos, Peter, Diamond, Jennifer R, Shagisultanova, Elena, Afghahi, Anosheh, Mayordomo, Jose, Wulfkuhle, Julia, Petricoin, Emanuel, Carter, Lisa, Zolman, Kathryn, Armstead, Stephanie, Winchester, Alyse, McSpadden, Tessa, Crawford, Gloria, Borges, Virginia, Gao, Dexiang, Richer, Jennifer
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Abstract PS12-14: Phase II trial of fulvestrant plus enzalutamide in ER+/Her2- advanced breast cancer
Elias, Anthony D, Spoelsta, Nicole, Vidal, Gregory A, Sams, Sharon, Kabos, Peter, Diamond, Jennifer R, Shagisultanova, Elena, Afghahi, Anosheh, Mayordomo, Jose, McSpadden, Tessa, Crawford, Gloria, Carter, Lisa, Zolman, Kathryn, Armstead, Stephanie, Winchester, Alyse, Borges, Virginia, Wulfkuhle, Julia, Petricoin, Emanuel, Gao, Dexiang, Richer, Jennifer
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article